U.S. Food and Drug Administration Issues NIR Guidance
On August 6, 2021, the U.S. Food and Drug Administration (FDA) released final guidance regarding near-infrared (NIR) analytical procedures. The guidance applies to new drug applications (NDAs), abbreviated new drug applications (ANDAs), and supplemental NDAs and ANDAs for small-molecule drugs. The FDA will address recommendations for NIR methods used in biologics under a future revision of the guidance.
The new guidance provides the agency’s recommendations for the development, validation, and use of NIR-based analytical procedures in evaluating a drug product’s identity, strength, quality, purity, and potency. The recommendations address the application of concepts described in FDA and International Council for Harmonization guidelines to NIR analytical procedures that use chemometric models. It also discusses submitting NIR documentation in applications.
The guidance does not discuss the development and validation of NIR analytical procedures or the setup, qualification, maintenance, or calibration of NIR instruments. The concepts of the guidance can be applied to other analytical technologies.
Artificial Intelligence Accelerates Molecular Vibration Analysis, Study Finds
July 1st 2025A new review led by researchers from MIT and Oak Ridge National Laboratory outlines how artificial intelligence (AI) is transforming the study of molecular vibrations and phonons, making spectroscopic analysis faster, more accurate, and more accessible.
Machine Learning and Optical Spectroscopy Advance CNS Tumor Diagnostics
July 1st 2025A new review article highlights how researchers in Moscow are integrating machine learning with optical spectroscopy techniques to enhance real-time diagnosis and surgical precision in central nervous system tumor treatment.
New Ecofriendly Spectrophotometric Method Boosts Accuracy in Veterinary Drug Analysis
June 30th 2025A recent study showcases a cost-effective, ecofriendly UV spectrophotometric method enhanced with dimension reduction algorithms to accurately quantify veterinary drugs dexamethasone and prednisolone, offering a sustainable alternative to traditional analysis techniques.
